Far Infrared Radiation for Sickle Cell Pain Management
Recruitment status was: Active, not recruiting
|Anemia, Sickle Cell||Radiation: Far Infrared Radiation (5μm to 20μm wavelength)||Phase 1|
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Phase 1 Study to Examine the Use of Far Infrared Radiation for Pain Management During Sickle Cell Crisis|
- Pain Management [ Time Frame: 40 minutes ]
|Study Start Date:||January 2008|
|Estimated Study Completion Date:||January 2009|
|Estimated Primary Completion Date:||September 2008 (Final data collection date for primary outcome measure)|
Far Infrared Radiation
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Far infrared radiation for 30 to 40 minutes during each session.
Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue.
It is hereby postulated that far infrared radiation of the body will promote blood and oxygen supply to the affected tissues. In addition, the analgesic properties of far infrared will alleviate pain due to the crisis.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00599482
|The Centre for Incurable Diseases|
|Mississauga, Ontario, Canada, L5R 3G9|
|Study Chair:||Ken Nedd, M.D.||GAAD Medical Research Institute Inc.|
|Study Director:||Kwasi Donyina, Ph.D.||GAAD Medical Research Institute Inc.|